Peter Greenleaf - Insider Trading & Ownership

Location
One Medimmune Way, Gaithersburg, MD
Summary
The estimated net worth of Peter Greenleaf is at least $14.2M dollars as of July 7, 2025. Peter Greenleaf is the Chief Executive Officer, Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $14.2M.
Signature
/s/ Peter Greenleaf
All Insider Reports
All Insider Reports

Ownership of Peter Greenleaf

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Chief Executive Officer, Director $14.2M -$2.87M -16.8% Feb 28, 2025
ATRS ANTARES PHARMA, INC. Director May 24, 2022
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Director Mar 22, 2022
CHRO Channel Therapeutics Corp Director Jul 2, 2025

Insider Transactions Reported by Peter Greenleaf:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.